Synapsoft logo
AI Insights from Disclosures
Searching...
HL GENOMICS Co., Ltd. 0156T0
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
HL GENOMICS Co., Ltd. is a company specializing in the development and manufacture of synthesis-based active pharmaceutical ingredients (APIs), mass-producing the active ingredients of pharmaceuticals by applying various core technologies, including organic synthesis and commercial production technology accumulated over many years and high-purity crystallization technology. The company possesses technology and a portfolio specialized in specific therapeutic areas such as the cardiovascular, respiratory, digestive, and neurological systems, for which demand continues to expand due to population aging and the increase in chronic diseases.
Representative Director Kim Hojin
Founded November 9, 2000
Corporation Type KOSDAQ
Industry Classification Manufacture of medicinal chemicals
Corporate number 13451-0044624
Business number 135-81-41887
Phone Number 031-335-2080
Fax Number 031-335-1314
Website hlgenomics.com
Company Address 1552 Bogaewonsam-ro, Wonsam-myeon, Cheoin-gu, Yongin-si, Gyeonggi-do

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant